Est. 2001·3,000+ placements · six offices · four regions
Barilla Group — source image

Image via City AM

Product Launchcurated sourcedetected 2026-05-25 · confidence 85%

Last updated

Barilla Group: Product Launch

Barilla Group launched BITE (Barilla Innovation & Technology Experience), a new innovation center for developing next-generation food products. The company is opening its Good Food Makers program (8th edition) for startup partnerships across three focus areas: smart onboarding, meal solutions, and mood-boosting snacks.

Source: City AM

The leadership read

Product momentum tends to widen the sector product and commercial leadership bench strength.

Market context: This lands while the Talent Market Index reads 112.9 (Hot) — up 11.4 versus the prior month — and EMEA signal share is easing (-3.2pts).

Barilla Group: 1 signal in the last 90 days; 0.1% of MitchelLake's EMEA signal flow.

MitchelLake in this thematic

More signals across EMEA

Product Launch · EMEA

Siteimprove

Siteimprove launched a new MCP (Model Context Protocol) Server that integrates accessibility capabilities into AI workflows across Lovable, Anthropic Claude, VS Code, and Figma, enabling automated accessibility in digital experience creation.

Product Launch · EMEA

ST Engineering

ST Engineering secured a US$87.1 million UK defence contract to provide nine variants of 40mm high and low velocity grenades to the military.

Product Launch · EMEA

CSL

CSL's Tavenos product faced a regulatory setback in the European Union, flagged as a potential challenge to the biotechnology major

Product Launch · EMEA

JFrog

JFrog is gaining analyst momentum for AI-focused tools and software supply chain security offerings, with strong traction in managing AI development workflows and securing cloud-native software pipelines.

Product Launch · EMEA

Globant

Globant introduced AI Pods-powered Synthetic Operator for automated live-stream monitoring, targeting mission-critical media workflows with agentic AI tools.

Product Launch · EMEA

MSD

MSD's pembrolizumab received NICE recommendation for locally advanced cervical cancer (LACC), representing first immunotherapy approval in this indication in England

Weekly briefing

Track companies like Barilla Group — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Share: WhatsApp · X · Email